EA201001053A1 - Состав для профилактики кандидозов - Google Patents

Состав для профилактики кандидозов

Info

Publication number
EA201001053A1
EA201001053A1 EA201001053A EA201001053A EA201001053A1 EA 201001053 A1 EA201001053 A1 EA 201001053A1 EA 201001053 A EA201001053 A EA 201001053A EA 201001053 A EA201001053 A EA 201001053A EA 201001053 A1 EA201001053 A1 EA 201001053A1
Authority
EA
Eurasian Patent Office
Prior art keywords
people
composition
patients
prevention
well
Prior art date
Application number
EA201001053A
Other languages
English (en)
Other versions
EA015747B1 (ru
Inventor
Тамаз Омарович МАНАШЕРОВ
Светлана Константиновна МАТЕЛО
Татьяна Владимировна КУПЕЦ
Original Assignee
Общество С Ограниченной Ответственностью "Вдс"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество С Ограниченной Ответственностью "Вдс" filed Critical Общество С Ограниченной Ответственностью "Вдс"
Priority to EA201001053A priority Critical patent/EA015747B1/ru
Priority to JP2013518309A priority patent/JP5932786B2/ja
Priority to LTEP11803866.0T priority patent/LT2545899T/lt
Priority to CN201410568964.6A priority patent/CN104274339A/zh
Priority to HUE11803866A priority patent/HUE048512T2/hu
Priority to PT118038660T priority patent/PT2545899T/pt
Priority to US13/635,909 priority patent/US20130039866A1/en
Priority to PL11803866T priority patent/PL2545899T3/pl
Priority to RS20191607A priority patent/RS59656B1/sr
Priority to CN2011800204075A priority patent/CN102858311A/zh
Priority to EP11803866.0A priority patent/EP2545899B1/en
Priority to UAA201212076A priority patent/UA107487C2/ru
Priority to ES11803866T priority patent/ES2766377T3/es
Priority to DK11803866.0T priority patent/DK2545899T3/da
Priority to PCT/RU2011/000407 priority patent/WO2012005622A1/ru
Priority to SI201131823T priority patent/SI2545899T1/sl
Publication of EA201001053A1 publication Critical patent/EA201001053A1/ru
Publication of EA015747B1 publication Critical patent/EA015747B1/ru
Priority to US14/729,463 priority patent/US9597276B2/en
Priority to CY20191101331T priority patent/CY1122427T1/el
Priority to HRP20192300TT priority patent/HRP20192300T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/733—Alginic acid; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A61K8/345—Alcohols containing more than one hydroxy group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/59—Mixtures

Abstract

Изобретение решает задачу практической реализации использующего доступные и безопасные компоненты эффективного профилактического состава, который может быть рекомендован для предупреждения развития кандидозов кожи и/или слизистых покровов у людей, которые входят в группу риска: больных сахарным диабетом, лиц с болезнями крови, с иммунодефицитом и другими тяжелыми патологиями, пациентов после курса гормональной терапии, лечения антибиотиками, химиотерапии, а также для грудных детей, беременных женщин; для людей, которые пользуются зубными протезами. Состав для профилактики кандидозов содержит активные компоненты, в качестве которых использованы ксилитол в количестве 0,3-20,0 мас.% и соли натрия или калия альгиновой кислоты либо их смесь в количестве 0,01-2,0 мас.%, а также инертные компоненты.
EA201001053A 2010-07-08 2010-07-08 Состав для профилактики кандидозов EA015747B1 (ru)

Priority Applications (19)

Application Number Priority Date Filing Date Title
EA201001053A EA015747B1 (ru) 2010-07-08 2010-07-08 Состав для профилактики кандидозов
CN2011800204075A CN102858311A (zh) 2010-07-08 2011-06-09 用于预防念珠菌病的组合物
EP11803866.0A EP2545899B1 (en) 2010-07-08 2011-06-09 Composition for the prophylaxis of candidiasis
CN201410568964.6A CN104274339A (zh) 2010-07-08 2011-06-09 用于预防念珠菌病的组合物
HUE11803866A HUE048512T2 (hu) 2010-07-08 2011-06-09 Kompozíció kandidiázis megelõzésére
PT118038660T PT2545899T (pt) 2010-07-08 2011-06-09 Composição para a profilaxia de candidíase
US13/635,909 US20130039866A1 (en) 2010-07-08 2011-06-09 Composition for the prophylaxis of candidiasis
PL11803866T PL2545899T3 (pl) 2010-07-08 2011-06-09 Kompozycja do zapobiegania kandydozie
RS20191607A RS59656B1 (sr) 2010-07-08 2011-06-09 Kompozicija za profilaksu kandidijaze
JP2013518309A JP5932786B2 (ja) 2010-07-08 2011-06-09 カンジダ症の予防のための組成物
LTEP11803866.0T LT2545899T (lt) 2010-07-08 2011-06-09 Kompozicija, skirta kandidozės profilaktikai
UAA201212076A UA107487C2 (ru) 2010-07-08 2011-06-09 Состав для профилактики кандидозов
ES11803866T ES2766377T3 (es) 2010-07-08 2011-06-09 Composición para la profilaxis de la candidiasis
DK11803866.0T DK2545899T3 (da) 2010-07-08 2011-06-09 Sammensætning til forebyggelse af candidiasis
PCT/RU2011/000407 WO2012005622A1 (ru) 2010-07-08 2011-06-09 Состав для профилактики кандидозов
SI201131823T SI2545899T1 (sl) 2010-07-08 2011-06-09 Sestavek za profilakso kandidoze
US14/729,463 US9597276B2 (en) 2010-07-08 2015-06-03 Composition for the prophylaxis of candidiasis
CY20191101331T CY1122427T1 (el) 2010-07-08 2019-12-18 Συνθεση για την προφυλαξη απο καντιντιαση
HRP20192300TT HRP20192300T1 (hr) 2010-07-08 2019-12-20 Pripravak za prevenciju kandidijaze

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA201001053A EA015747B1 (ru) 2010-07-08 2010-07-08 Состав для профилактики кандидозов

Publications (2)

Publication Number Publication Date
EA201001053A1 true EA201001053A1 (ru) 2011-10-31
EA015747B1 EA015747B1 (ru) 2011-10-31

Family

ID=44925755

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201001053A EA015747B1 (ru) 2010-07-08 2010-07-08 Состав для профилактики кандидозов

Country Status (17)

Country Link
US (2) US20130039866A1 (ru)
EP (1) EP2545899B1 (ru)
JP (1) JP5932786B2 (ru)
CN (2) CN104274339A (ru)
CY (1) CY1122427T1 (ru)
DK (1) DK2545899T3 (ru)
EA (1) EA015747B1 (ru)
ES (1) ES2766377T3 (ru)
HR (1) HRP20192300T1 (ru)
HU (1) HUE048512T2 (ru)
LT (1) LT2545899T (ru)
PL (1) PL2545899T3 (ru)
PT (1) PT2545899T (ru)
RS (1) RS59656B1 (ru)
SI (1) SI2545899T1 (ru)
UA (1) UA107487C2 (ru)
WO (1) WO2012005622A1 (ru)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104955462A (zh) * 2012-11-26 2015-09-30 阿波罗尼亚保健股份有限公司 用于治疗或预防龋齿的组合物、用途和方法
RU2014105805A (ru) * 2013-06-07 2015-08-27 Валерий Валентинович Правдин Многофункциональная зубная паста
CA2920110C (en) 2013-08-08 2022-05-31 Novan, Inc. Compositions and kits including a nitric oxide releasing compound and a hydrogel
US10322082B2 (en) 2014-07-11 2019-06-18 Novan, Inc. Topical antiviral compositions and methods of using the same
CN104434686A (zh) * 2014-12-10 2015-03-25 唯美度科技（北京）有限公司 一种含红加仑提取物眼霜及其制备方法
WO2018203327A1 (en) * 2017-04-30 2018-11-08 Resdevco Research And Development Co. Ltd. Composition containing phenethyl alcohol for treatment of candida infection
EP3698769B1 (en) * 2019-02-22 2023-06-07 Steven De Mars An oral remineralization accelerating composition
MX2021011355A (es) * 2019-03-18 2021-10-13 Sunstar Americas Inc Composicion para cuidado oral.

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0199806A4 (en) * 1984-11-08 1988-06-13 Zetachron Inc TOOTHPASTE CONTAINING ALGINATE CALCIUM CHELATING AGENT.
JPH0655659B2 (ja) * 1985-04-10 1994-07-27 ライオン株式会社 練歯磨の製造方法
US4775525A (en) * 1985-12-16 1988-10-04 Ivo Pera Oral hygiene formulation containing sodium alginate
GB9212706D0 (en) * 1992-06-16 1992-07-29 Smithkline Beecham Plc Novel composition
ATE275927T1 (de) * 1992-10-28 2004-10-15 Den Mat Corp Antibakterielles mundwasser
GB9402877D0 (en) 1994-02-15 1994-04-06 Torchinsky Alick Mouthwash
US5695746A (en) * 1995-07-28 1997-12-09 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Liquid dentifrice with mouthwash fresh taste
WO1998011867A1 (en) * 1996-09-20 1998-03-26 Warner-Lambert Company Oral compositions containing a zinc compound
CN1286468C (zh) * 1997-04-30 2006-11-29 雷克特本克斯尔保健(英国)有限公司 含藻酸或藻酸盐的药物组合物
ES2132033B1 (es) * 1997-11-06 2000-03-01 Dentaid Sa Composicion oral para el tratamiento de la halitosis.
FI974385A0 (fi) * 1997-12-01 1997-12-01 Xyrofin Oy Anvaendning av xylitol foer bekaempning av jaestinfektion och xylitolpreparat foer denna anvaendning
JP2000333973A (ja) * 1999-05-28 2000-12-05 Lion Corp キシリトールを含有する義歯安定剤
DE19941933A1 (de) * 1999-09-03 2001-03-15 Cognis Deutschland Gmbh Tensidsysteme
US6531141B1 (en) * 2000-03-07 2003-03-11 Ortho-Mcneil Pharmaceutical, Inc. Oil-in-water emulsion containing tretinoin
KR100537834B1 (ko) * 2000-12-21 2005-12-19 주식회사 엘지생활건강 목단피 추출물을 유효성분으로 함유하는 구취 억제용 구강 조성물
NL1018421C1 (nl) * 2001-06-29 2003-01-07 Sara Lee De Nv Mondverzorgingsmiddel.
JP2003081795A (ja) * 2001-09-17 2003-03-19 Lion Corp 歯磨組成物
EP1297821A1 (en) * 2001-10-01 2003-04-02 Hive of Beauty (Europe) BVBA Skin treatment compositions
US20040057908A1 (en) * 2001-12-13 2004-03-25 Bowen William H. Oral compositions and use thereof
CN1433752A (zh) * 2002-01-21 2003-08-06 权力敏 海洋生物素净足液
JP2004269437A (ja) * 2003-03-10 2004-09-30 Nissen Techno:Kk 歯磨き剤
CA2526626C (en) * 2003-05-29 2012-08-28 Sun Pharmaceuticals Corporation Emulsion base for skin care compositions
US8524198B2 (en) * 2003-06-20 2013-09-03 Donald W. Bailey Xylitol dental maintenance system
EP1660038B1 (en) * 2003-07-30 2014-08-27 Stiefel Laboratories, Inc. Steroidal compositions containing hydroxycarboxylic acids and methods of using the same
JP2005187333A (ja) * 2003-12-24 2005-07-14 Lion Corp う蝕予防用塗布剤組成物
CN101299956A (zh) * 2004-07-02 2008-11-05 迪斯卡斯牙科有限责任公司 牵开装置
US8858920B2 (en) * 2004-12-21 2014-10-14 Colgate-Palmolive Company Anti-caries oral care composition with xylitol
JP2008303188A (ja) * 2007-06-08 2008-12-18 Univ Of Tokushima カンジダバイオフィルム除去剤
JP4919060B2 (ja) * 2007-06-28 2012-04-18 ライオン株式会社 口腔用組成物及びアルジンジパイン阻害剤
US8828363B2 (en) * 2007-08-03 2014-09-09 Gary H. EIREW Pharmaceutical composition for improving oral hygiene and methods thereof

Also Published As

Publication number Publication date
DK2545899T3 (da) 2020-01-27
RS59656B1 (sr) 2020-01-31
UA107487C2 (ru) 2015-01-12
US20150265517A1 (en) 2015-09-24
LT2545899T (lt) 2020-01-27
EP2545899A1 (en) 2013-01-16
CY1122427T1 (el) 2021-01-27
EP2545899A4 (en) 2015-11-04
US9597276B2 (en) 2017-03-21
CN102858311A (zh) 2013-01-02
PL2545899T3 (pl) 2020-05-18
WO2012005622A1 (ru) 2012-01-12
CN104274339A (zh) 2015-01-14
HUE048512T2 (hu) 2020-08-28
EP2545899B1 (en) 2019-11-27
HRP20192300T1 (hr) 2020-03-06
SI2545899T1 (sl) 2020-02-28
PT2545899T (pt) 2019-12-18
JP5932786B2 (ja) 2016-06-08
US20130039866A1 (en) 2013-02-14
JP2013530221A (ja) 2013-07-25
ES2766377T3 (es) 2020-06-12
EA015747B1 (ru) 2011-10-31

Similar Documents

Publication Publication Date Title
EA201001053A1 (ru) Состав для профилактики кандидозов
MX362452B (es) Tratamiento de degeneracion macular relacionada con la edad (amd) usando virus asociados con adeno (aav) sflt-1.
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
EA201690069A1 (ru) Применение высоких доз придопидина для лечения болезни хантингтона
PH12015502539B1 (en) Cenicriviroc compositions and methods of making and using the same
EA201390332A1 (ru) Дейтерированные аналоги придопидина, применимые в качестве допаминергических стабилизаторов
EA201590166A8 (ru) Комбинированная терапия для лечения рассеянного склероза
HRP20192189T1 (hr) Doziranja i terapijske primjene l-4-klorokinurenina
RU2012113101A (ru) Композиция для наружного применения на коже, содержащая соль и сахар в качестве активных ингредиентов, для предотвращения и лечения вагиноза и ее применение
JP2020500864A5 (ru)
MX341660B (es) Agonista del receptor de ghrelina para el tratamiento de caquexia.
Razikova The condition of tissues in the oral cavity of patients with complications of arterial hypertension COVID-19
EA201401155A1 (ru) Препарат и способ профилактики и лечения атипичного остеопороза
RU2014150946A (ru) Способ снижения веса
MX2008015323A (es) Composicion farmaceutica que comprende ciclobenzaprina y aceclofenac en asociacion.
ES2746002T3 (es) Aplicación de homogeneizado de larvas de zánganos adsorbido y de vitamina D3 o vitaminas del grupo d y/o metabolitos activos de las mismas para prevenir y tratar enfermedades víricas
BR112017022478A2 (pt) composição farmacêutica de liberação sustentada que contém rivastigmina
KR20170011441A (ko) 유황을 유효성분으로 포함하는 대상포진 질병 치료제.
TW200626133A (en) Oral medication for twice-daily administration
RU2014101958A (ru) Фармацевтическая композиция для лечения зависимости у людей
RU2013148539A (ru) Алиспоривир для лечения инфекции вируса гепатита с
Jennings et al. Necrotic tongue: a rare manifestation of giant cell arteritis
RU2012114097A (ru) Терапевтический агент против хронической боли
McCullough Managing HIV in general practice
RU2612011C1 (ru) Энтеросорбент

Legal Events

Date Code Title Description
QB4A Registration of a licence in a contracting state
QB4A Registration of a licence in a contracting state